Inceptionr LLC Incyte Corp Transaction History

Inceptionr LLC

  • $354 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
BUY
$56.55 - $66.59 $708,741 - $834,572
12,533 Added 329.12%
16,341 $931 Million
Q4 2023

Feb 08, 2024
SELL
$52.16 - $64.19 $342,952 - $422,049
-6,575 Reduced 63.32%
3,808 $239 Million
Q3 2023

Nov 14, 2023
BUY
$57.77 - $65.93 $599,825 - $684,551
10,383 New
10,383 $600 Million
Q1 2023

May 12, 2023
BUY
$70.23 - $86.01 $1.05 Million - $1.29 Million
15,019 New
15,019 $1.09 Billion

Others Institutions Holding INCY

# of Institutions
629
Shares Held
198M
Call Options Held
766K
Put Options Held
476K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email